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Abstract
Infective endocarditis involving the right side of the heart is typically associated with IV drug
abuse and chronic indwelling catheters which commonly involve the tricuspid valve. Isolated
pulmonary valve endocarditis (PVE) is a rare clinical entity. We report a rare case of a young
woman with a history of end-stage renal disease (ESRD) on hemodialysis through tunneled
catheter presenting with persistent coagulase-negative staphylococcus (CoNS) epidermidis
bacteremia despite being on appropriate treatment with IV vancomycin for two weeks. Because
of the persistent bacteremia, a transesophageal echocardiogram was performed and it revealed
a thickened pulmonary valve with 1.8 cm vegetation in the left posterior cusp. She was
successfully treated with IV daptomycin course for a total of six weeks. The recommended
management for PVE is usually medical treatment with IV antibiotics gauged according to
sensitivities of the cultures. Our article highlights the fact that the decision to manage it
medically versus surgically can propose a challenge as the guidelines are not very robust.
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Introduction
Isolated pulmonary valve endocarditis (PVE) is an extremely rare condition. We present a
patient with PVE caused by coagulase-negative staphylococcus (CoNS) epidermidis that was
successfully treated with IV antibiotics. The recommended management for PVE is usually
medical treatment with IV antibiotics gauged according to sensitivities of the cultures. The
surgical intervention in right-sided native valve endocarditis can be considered in recurrent
septic pulmonary embolic, persistent bacteremia with highly resistant organisms and
vegetations ≥ 20 mm in diameter. Our patient was managed as per the current guidelines with
IV antibiotics [1]. Isolated PVE is a rarely reported entity, so this article highlights the
significance of its appropriate treatment.
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Case Presentation
A 30-year-old woman with end-stage renal disease (ESRD) due to polycystic kidney disease on
hemodialysis through a tunneled catheter was referred by her nephrologist for persistent CoNS
bacteremia, low-grade fever, malaise, and myalgia for more than two weeks. Her first
outpatient blood cultures grew oxacillin resistant staphylococcus epidermis (sensitivities are
shown in Table 1) and the patient was appropriately started on vancomycin (renally dosed). As
the patient continued to have symptoms and blood cultures collected at different occasions
were persistently positive for the same organism despite being on vancomycin, it prompted the
outpatient nephrologist to refer the patient for hospitalization and further evaluation.
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Antibiotics

Sensitivities (mic)

Ampicillin/Sulbactam

Resistant (<=8/4)

Cefazolin

Resistant (<=4)

Clindamycin

Sensitive (0.5)

Erythromycin

Resistant (>4)

Gentamicin

Sensitive (<=1)

Oxacillin

Resistant (>2)

Penicillin

Resistant (>8)

Rifampin

Sensitive (<=1)

Tetra/Doxy

Sensitive (2)

Trimethoprim/Sulfamethoxazole

Sensitive (<=0.5/9.5)

Vancomycin

Sensitive (2)

TABLE 1: Sensitivities.
Blood cultures, R=resistant to the antibiotic, S=sensitive to the antibiotic.

The patient was admitted to the hospital with a diagnosis of persistent bacteremia from the
possible source being the tunneled hemodialysis catheter. She was started on IV daptomycin as
she failed to respond to vancomycin. A transthoracic echocardiogram (TTE) was obtained upon
admission to screen for endocarditis (Figure 1 ) which did not show any vegetations and ruled
out any underlying valvular diseases including pulmonary regurgitation.
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FIGURE 1: TTE.
No evidence of vegetations on the valves.
TTE, transthoracic echocardiogram

Given a high index of suspicion for endocarditis, a transesophageal echocardiogram was
performed which revealed a thickened pulmonary valve with elongated, mobile, 1.8 cm
vegetation on the left leaflet of the pulmonary valve without evidence of valvular regurgitation
(Figure 2). The bacteremia resolved with IV daptomycin treatment and the patient underwent
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replacement of a tunneled dialysis catheter.

FIGURE 2: Transesophageal echocardiogram.
Pulmonary valve vegetation as shown by the arrowhead.

The patient was also evaluated by cardiothoracic surgery; however, surgical intervention was
not recommended in view of clinical improvement and no significant damage to the valve.
A repeat TEE was performed after the completion of six weeks of daptomycin therapy which
showed complete resolution of the vegetation with preserved valve function (Figure 3).
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FIGURE 3: Transesophageal echocardiogram.
Resolution of vegetation after intravenous therapy.

Discussion
Isolated PVE is an extremely rare entity to be described in the medical literature which can
present with nonspecific signs and symptoms such as fever, pleuritic chest pain, hemoptysis,
and delayed onset diastolic murmur [2-4]. The common precipitating factor for PVE includes IV
drug use, immunosuppression, valvular replacement, congenital heart diseases, alcoholism, and
catheter-related infections as suggested in our case described [2, 4-5]. IV drug use is the most
common (90%) cause of infective endocarditis on the right side of the heart and majorly
involves the tricuspid valve (>90%) [6]. Given the low incidence of PVE (1.5%-2%), it can pose a
challenge for physicians for prompt diagnosis hence risking timely management of the
infection [7].
In general, TTE is usually performed as the first diagnostic test in patients suspected of
infective endocarditis. Even though the sensitivity of TTE is high (40%-63%), normal valvular
imaging and function do not exclude the suspicion of endocarditis. In this situation, TEE is
performed which has higher sensitivity (90%-100%) in detecting vegetations and valvular
abscesses [8-9]. As discussed above in our case, the initial TTE failed to reveal any pulmonary
valve abnormality even though anatomically speaking the pulmonary valve is closer to the
chest wall. Later, TEE was able to detect 1.8 cm mobile mass on the pulmonary valve
confirming the diagnosis of infective endocarditis.
Several microorganisms have been identified for causing infective endocarditis in pulmonary
valves which includes Staphylococcus species (>50%), Streptococcus species (>10%),
Enterococcus species (9%), and fungal organism (>4%). Infections with CoNS account for
roughly 2% of the PVE among Staphylococcus species. As the incidence of PVE with CoNS is so
low, this article is unique in describing an interesting case of Staphylococcus epidermidis PVE
with complete resolution [10-11].
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Pulmonary valve endocarditis usually follows a benign course and responds
appropriately to medical management with IV antibiotics along with supportive care [12]. The
role of surgical intervention has been discussed in persistent bacteremia especially with
resistant organisms, complications such as abscess formation, and recurrent septic pulmonary
embolism. Hemodynamic un-stability, vegetations >20 mm, and Staphylococcus infection are
also considered indications for surgical consultation in right-sided endocarditis [13-17]. As
described above in our patient’s clinical course, surgical intervention was deferred because she
responded well and appropriately with medical management. Nevertheless, it is important to
understand that surgical consultation was appropriate from the beginning of the clinical
course, should there be any evidence of clinical deterioration, lack of response to antibiotic
therapy, or superimposed impressive pulmonary valve stenosis or insufficiency.
It was interesting to note that this was the second time our patient had bacteremia with
Staphylococcus epidermidis. The previous episode of bacteremia was reported in 2016 and the
patient responded well with IV antibiotics and the tunneled catheter was replaced (sensitivities
are shown in Table 2). During current hospitalization, it was interesting to note that even
though the blood cultures for Staphylococcus epidermis bacteria were sensitive to vancomycin
(MIC 2), the blood infection failed to respond to vancomycin. The patient was initiated on
daptomycin with a dosing of 6 mg/kg posthemodialysis which resulted in clearing off the
bacteremia. She was continued on this antibiotic regimen for a total of six weeks with close
monitoring of creatine phosphokinase. There has been limited data in the usage and efficacy of
daptomycin against CoNS infections though daptomycin has been shown to have good in vitro
bactericidal activity in oxacillin resistant CoNS infections [18-19]. Our clinical scenario
provides substantial evidence that daptomycin can be used as an alternative for oxacillin
resistant CoNS infections with good results.
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Antibiotics

Sensitivities (mic)

Ciprofloxacin

Sensitive (<=1)

Levofloxacin

Sensitive (<=1)

Clindamycin

Resistant (>4)

Erythromycin

Resistant (>4)

Gentamicin

Intermediate (8)

Oxacillin

Sensitive (<=0.25)

Penicillin

Resistant (2)

Rifampin

Sensitive (<=1)

Tetra/Doxy

Sensitive (<=4)

Trimethoprim/Sulfamethoxazole

Sensitive (<=0.5/9.5)

Vancomycin

Sensitive (4)

TABLE 2: Sensitivities.
Previous blood cultures in 2016, R=resistant to the antibiotic, S=sensitive to the antibiotic.

Conclusions
This article summarizes a unique case of isolated PVE with CoNS from the tunneled
hemodialysis catheter. As this condition is extremely rare and diagnosis is often challenging, a
high index of suspicion should be maintained when evaluating high-risk patients. It is
important to keep in mind that endocarditis can often be missed on a simple TTE and it is
almost mandatory to get a transesophageal echocardiogram to visualize all the cardiac
structures appropriately. Treating endocarditis involves multi-specialties of medicine and
surgery which is duly suggested for its proper management.
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